ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹22 Cr | ₹25 Cr | ₹13 Cr | ₹11 Cr | ₹19 Cr |
What is the latest Total Debt ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹22 Cr |
| Mar2024 | ₹25 Cr |
| Mar2023 | ₹13 Cr |
| Mar2022 | ₹11 Cr |
| Mar2021 | ₹19 Cr |
How is Total Debt of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹22 Cr | -14.24 | |
| Mar2024 | ₹25 Cr | 89.68 | |
| Mar2023 | ₹13 Cr | 21.01 | |
| Mar2022 | ₹11 Cr | -42.62 | |
| Mar2021 | ₹19 Cr | - | |
Compare Total Debt of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,054.3 Cr | -0.5% | -9.2% | -4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -0.5% |
-9.2% |
-4% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses